The challenge of selecting tumor antigens for chimeric antigen receptor T-cell therapy in ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The challenge of selecting tumor antigens for chimeric antigen receptor T-cell therapy in ovarian cancer

Published:2022-09-29 Issue:12 Volume:39 Page:
ISSN:1559-131X
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Ding Haigang,Zhang Juan,Zhang Feng,Xu Yan,Yu Yijun,Liang Wenqing^ORCID,Li Qingping

Funder

Public Technology Applied Research Projects of Zhejiang Province

Medical and Health Research Project of Zhejiang Province

Traditional Chinese Medicine Science and Technology Projects of Zhejiang Province

Research Fund Projects of The Affiliated Hospital of Zhejiang Chinese Medicine University

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12032-022-01824-7.pdf

Reference86 articles.

1. Ovarian cancer statistics. [cited 2021 7.1.2021]; Available from: https://www.wcrf.org/dietandcancer/ovarian-cancer-statistics/.

2. Yan W, Hu H, Tang B. Advances of chimeric antigen receptor T cell therapy in ovarian cancer. Onco Targets Ther. 2019;12:8015.

3. Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2017;41:3–14.

4. Ovarian Cancer Stages. [cited 2021 1.7.2021]; Available from: https://www.cancer.org/cancer/ovarian-cancer/detection-diagnosis-staging/staging.html.

5. Bookman M. Standard treatment in advanced ovarian cancer in 2005: the state of the art. Int J Gynecol Cancer. 2005;15:Suppl 3.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP